Group Leader, Milner Therapeutics Institute
Konstantinos Tzelepis's group is uncovering epigenetic and epitranscriptomic mechanisms that are implicated in cancer initiation and maintenance. Learn more
Research AreasCancer epigenetics
Acute myeloid leukaemia
Technology development
Novel therapeutics
|
TechniquesCRISPR
Genetic Screening
|
Research Theme
